sodium fluoride 2.2 MG Chewable Tablet [Nafrinse]
RxNorm concept 1302475, branded drug (sbd). Prescribable name: Nafrinse 2.2 MG Chewable Tablet.
- RxCUI
- 1302475
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1302475 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Related concepts
- sodium fluoride 2.2 MG (SCDC, consists of)
- sodium fluoride 2.2 MG [Nafrinse] (SBDC, consists of)
- Chewable Tablet (DF, has dose form)
- Nafrinse (BN, has ingredient)
- sodium fluoride 2.2 MG Chewable Tablet (SCD, tradename of)
Linked data
NDCs
- 10733056704
- 10733056705
- 10733056706
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1302475 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1302475 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1302475. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.